A randomized controlled trial: comparing extracorporeal shock wave therapy versus local corticosteroid injection for the treatment of carpal tunnel syndrome

Int Orthop. 2020 Jan;44(1):141-146. doi: 10.1007/s00264-019-04432-9. Epub 2019 Oct 26.

Abstract

Purpose: Extracorporeal shock wave therapy (ESWT) has been reported as a new therapy for carpal tunnel syndrome (CTS). However, few studies have compared ESWT with the local corticosteroid injection (LCI).

Methods: In this study, a randomized controlled trial comparing 30 patients with ESWT and 25 patients treated with LCI was conducted. The clinical outcomes were obtained with tests including the visual analog scale (VAS) for pain and paresthesia, the Boston Carpal Tunnel Questionnaire (BQ), and a nerve conduction study, before the study started and at three, nine, and 12 weeks after the start of the treatment.

Results: Significantly greater improvement in the VAS and BQ scores was noted for the ESWT group than for the LCI group (P < 0.05). For the nerve conduction study, there was a significant improvement in the median nerve sensory nerve action potential distal latency at the nine and 12-week follow-ups for the ESWT group.

Conclusions: ESWT is a useful noninvasive short-term treatment for mild to moderate carpal tunnel syndrome and elicits a better recovery than LCI does, but more research is needed to test the clinical outcomes of ESWT.

Keywords: Carpal tunnel syndrome; Nerve conduction study; Shock waves.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Betamethasone / administration & dosage*
  • Carpal Tunnel Syndrome / therapy*
  • Extracorporeal Shockwave Therapy*
  • Female
  • Glucocorticoids / administration & dosage*
  • Humans
  • Injections
  • Male
  • Median Nerve / drug effects*
  • Middle Aged
  • Prospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Betamethasone